Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.
van Kessel, Emma; Baumfalk, Anniek E.; van Zandvoort, Martine J. E.et al.
2017 • In Journal of Neuro-Oncology, 134 (1), p. 9-18
[en] Deficits in neurocognitive functioning (NCF) frequently occur in glioma patients. Both treatment and the tumor itself contribute to these deficits. Data about the role of the tumor are scarce, because NCF has mostly been studied postoperatively. We aimed to summarize data on pre-treatment NCF in glioma patients and to determine the overall and domain-specific prevalence of neurocognitive dysfunction. We searched PubMed and Embase according to PRISMA-P protocol for studies that evaluated pre-treatment NCF in glioma patients (1995-November 2016) and extracted information about NCF. We performed analysis of data for two main outcome measures; mean cognitive functioning of the study sample (at group level) and the percentage of impaired patients (at individual level). We included 23 studies. Most studies were small observational prospective cohort studies. In 11 (47.5%) studies, patient selection was based on tumor location. NCF was analyzed at the group level in 14 studies, of which 13 (92.9%) found decreased NCF at group level, compared to normative data or matched controls. The proportion of individuals with decreased NCF was reported in 15 studies. NCF was impaired (in any domain) in 62.6% of the individuals (median; interquartile range 31.0-79.0). Cognitive impairments were more common in patients with high-grade glioma than with low-grade glioma (OR 2.50; 95% CI 1.71-3.66). Cognitive impairment occurs in the majority of treatment-naive glioma patients, suggesting that neurocognitive dysfunction is related to the tumor. However, the literature about pre-treatment NCF in glioma patients is characterized by small-scale studies and strong heterogeneity in patient selection, resulting in high risk of bias.
Disciplines :
Genetics & genetic processes
Author, co-author :
van Kessel, Emma
Baumfalk, Anniek E.
van Zandvoort, Martine J. E.
Robe, Pierre ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques
Snijders, Tom J.
Language :
English
Title :
Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.
Kayl AE, Meyers CA (2003) Does brain tumor histology influence cognitive function? Neuro Oncol 5: 255–260
Santini B, Talacchi A, Squintani G, Casagrande F, Capasso R, Miceli G (2012) Cognitive outcome after awake surgery for tumors in language areas. J Neurooncol 108:319–326
Talacchi A, Santini B, Savazzi S, Gerosa M (2011) Cognitive effects of tumour and surgical treatment in glioma patients. J Neurooncol 103:541–549
Sanai N, Chang S, Berger MS (2011) Low-grade gliomas in adults. J Neurosurg 115:948–996
Aaronson NK, Taphoorn MJ, Heimans JJ et al (2011) Compromised health-related quality of life in patients with low-grade glioma. J Clin Oncol 29:4430–4435
Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55:992–999
Weitzner MA, Meyers CA, Byrne K (1996) Psychosocial functioning and quality of life in patients with primary brain tumors. J Neurosurg 84:29–34
Tucha O, Smely C, Preier M, Lange KW (2000) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47:324–333
Kaleita TA, Wellisch DK, Cloughesy TF et al (2004) Prediction of neurocognitive outcome in adult brain tumor patients. J Neurooncol 67:245–253
Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3:159–168
Cairncross G, Wang M, Shaw E et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma; long-term resuts of RTOG 9402. J Clin Oncol 31:337–343
Kolker S, Pawlak V, Ahlemeyer B et al (2002) NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria. Eur J Neurosci 16:21–28
Bosma I, Douw L, Bartolomei F et al (2008) Synchronized brain activity and neurocognitive function in patients with low-grade glioma: a magnetoencephalography study. Neuro Oncol 10:734–744
Wu AS, Witgert ME, Lang FF et al (2011) Neurocognitive function before and after surgery for insular gliomas. J Neurosurg 115:1115–1125
Yoshii Y, Tominaga D, Sugimoto K et al (2008) Cognitive function of patients with brain tumor in pre- and postoperative stage. Surg Neurol 69:51–61
Soffietti R, Baumert BG, Bello L et al (2010) Guidelines on management of low-grade gliomas: report of an EFNS–EANO task force. Eur J Neurol 17:1124–1133
Lezak MD, Howieson DB, Bigler ED, Tranel D (2012) Neuropsychological assessment. Oxford University Press Inc, Oxford
Charras P, Herbet G, Deverdun J et al (2014) Functional reorganization of the attentional networks in low-grade glioma patients: a longitudinal study. Cortex 63C:27–41
Habets EJ, Kloet A, Walchenbach R, Vecht CJ, Klein M, Taphoorn MJ (2014) Tumour and surgery effects on cognitive functioning in high-grade glioma patients. Acta Neurochir 156:1451–1459
Bryszewski B, Tybor K, Ormezowska EA, Jaskolski DJ, Majos A (2013) Rearrangement of motor centers and its relationship to the neurological status of low-grade glioma examined on pre- and postoperative fMRI. Clin Neurol Neurosurg 115:2464–2470
Satoer D, Visch-Brink E, Smits M et al (2014) Long-term evaluation of cognition after glioma surgery in eloquent areas. J Neurooncol 116:153–160
Hu XH, Lei T, Xu HZ, Zou YJ, Liu HY (2013) Resting-state magnetoencephalography study of “small world” characteristics and cognitive dysfunction in patients with glioma. Oncol Targets Ther 6:311–313
van Dellen E, Douw L, Hillebrand A et al (2012) MEG network differences between low- and high-grade glioma related to epilepsy and cognition. PLoS ONE 7:e50122
Mu YG, Huang LJ, Li SY et al (2012) Working memory and the identification of facial expression in patients with left frontal glioma. Neuro Oncol 14(Suppl 4):iv81–i9
Satoer D, Vork J, Visch-Brink E, Smits M, Dirven C, Vincent A (2012) Cognitive functioning early after surgery of gliomas in eloquent areas. J Neurosurg 117:831–838
Bizzi A, Nava S, Ferre F et al (2012) Aphasia induced by gliomas growing in the ventrolateral frontal region: assessment with diffusion MR tractography, functional MR imaging and neuropsychology. Cortex 48:255–272
Miotto EC, Junior AS, Silva CC et al (2011) Cognitive impairments in patients with low grade gliomas and high grade gliomas. Arq Neuropsiquiatr 69:596–601
Ruge MI, Ilmberger J, Tonn JC, Kreth FW (2011) Health-related quality of life and cognitive functioning in adult patients with supratentorial WHO grade II glioma: status prior to therapy. J Neurooncol 103:129–136
Ek L, Almkvist O, Wiberg MK, Stragliotto G, Smits A (2010) Early cognitive impairment in a subset of patients with presumed low-grade glioma. Neurocase 16:503–511
Campanella F, Mondani M, Skrap M, Shallice T (2009) Semantic access dysphasia resulting from left temporal lobe tumours. Brain 132:87–102
Le Rhun E, Delbeuck X, Devos P, Pasquier F, Dubois F (2009) Cognitive disorders and adult grade II and III gliomas: analysis of a series of 15 patients. Neurochirurgie 55:303–308
Teixidor P, Gatignol P, Leroy M, Masuet-Aumatell C, Capelle L, Duffau H (2007) Assessment of verbal working memory before and after surgery for low-grade glioma. J Neurooncol 81:305–313
Thomson AM, Taylor R, Fraser D, Whittle IR (1997) Stereotactic biopsy of nonpolar tumors in the dominant hemisphere: a prospective study of effects on language functions. J Neurosurg 86:923–926
Cochereau J, Herbet G, Duffau H (2016) Patients with incidental WHO grade II glioma frequently suffer from neuropsychological disturbances. Acta Neurochir 158:305–312
Liu Y, Zhou R, Sulman E, Schreurer ME et al (2015) Genetic Modulation of Neurocognitive function in Glioma Patients. Clin Cancer Res 21:3340–3346
Noll KR, Bradshaw ME, Weinberg JS, Wefel JS (2015) Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma. Psycho-Oncology. doi:10.1002/pon4046 [ePub ahead of print]
Racine CA, Li J, Molinaro AM, Butowski N, Berger MS (2015) Neurocognitive function in newly diagnosed low-grade glioma patients undergoing surgical resection with awake mapping techniques. Neurosurgery 77:371–379
Wefel JS, Noll KR, Rao G, Cahill DP (2016) Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection. Neuro-Oncology 18(12):1656–1663
Correa DC, Satagopan J, Cheung K, Arora AK, Kryza-Lacombe M, Xu Y et al. (2016) COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors. Neuro-Oncology 18(10):1425–1433
Van Loon EMP, Heijenbrok-Kal MH, Van Loon WS, Van den Bent MJ, Vincent AJPE, De Koning I et al (2015) Assessment methods and prevalence of cognitive dysfunction in patients with low-grade glioma: a systematic review. J Rehabil Med 47:481–488
Gehring K, Sitskoorn MM, Gundy CM et al (2009) Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol 27(22):3712–3722